A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC. Cortiula F, Naidoo J. Lung Cancer 2023;181:107256.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cortiula F, Naidoo J. A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC. Lung Cancer 2023;181:107256.
PMID: 37267713